AB Science Operating Margin from 2010 to 2026
| AB Stock | EUR 1.34 0.05 3.60% |
Check AB Science financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AB Science's main balance sheet or income statement drivers, such as Depreciation And Amortization of 633.5 K, Interest Expense of 919.5 K or Selling General Administrative of 2.8 M, as well as many indicators such as Price To Sales Ratio of 47.89, Dividend Yield of 0.0077 or Days Sales Outstanding of 581. AB Science financial statements analysis is a perfect complement when working with AB Science Valuation or Volatility modules.
AB Science | Operating Margin |
Analyzing AB Science's Operating Margin over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Operating Margin has evolved provides context for assessing AB Science's current valuation and future prospects.
Latest AB Science's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of AB Science SA over the last few years. It is AB Science's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AB Science's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (5.30) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
AB Science Operating Margin Regression Statistics
| Arithmetic Mean | (11.63) | |
| Coefficient Of Variation | (50.82) | |
| Mean Deviation | 4.74 | |
| Median | (9.32) | |
| Standard Deviation | 5.91 | |
| Sample Variance | 34.94 | |
| Range | 21.1463 | |
| R-Value | 0.36 | |
| Mean Square Error | 32.54 | |
| R-Squared | 0.13 | |
| Significance | 0.16 | |
| Slope | 0.42 | |
| Total Sum of Squares | 559.12 |
AB Science Operating Margin History
About AB Science Financial Statements
AB Science stakeholders use historical fundamental indicators, such as AB Science's Operating Margin, to determine how well the company is positioned to perform in the future. Although AB Science investors may analyze each financial statement separately, they are all interrelated. For example, changes in AB Science's assets and liabilities are reflected in the revenues and expenses on AB Science's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in AB Science SA. Please read more on our technical analysis and fundamental analysis pages.
AB Science S.A., a pharmaceutical company, engages in the discovery, development, and commercialization of protein kinase inhibitors for use in human and veterinary medicines. AB Science S.A. was founded in 2001 and is headquartered in Paris, France. AB SCIENCE operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. It employs 123 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in AB Science Stock
AB Science financial ratios help investors to determine whether AB Science Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AB Science with respect to the benefits of owning AB Science security.